Jake Jorgovan

NOVEMBER 27, 2023

Biopharmaceutical Consulting: Supporting every aspect of the biopharma value chain, including R&D, operations, manufacturing, commercialization, and mergers and acquisitions (M&A). They focus particularly on EHR, emphasizing its implementation, training, activation, and optimization to enhance healthcare services.

Life science 130

Life science Biopharmaceuticals Biotech Mergers and acquisition activities 130

Frost & Sullivan

MAY 9, 2025

The Expanding Role of Clinical Contract Peripheral Services As the pharmaceutical and biopharma industries recalibrate after the COVID-19 pandemic, clinical trial outsourcing has surged, creating significant opportunities for contract research organizations (CROs). The global CRO industry, valued at $66.39 billion by 2030.

Mergers and acquisition activities 52

Mergers and acquisition activities Biopharma Biotechnology Biotech 52

Frost & Sullivan

JANUARY 23, 2025

The 43rd JP Morgan Healthcare Conference , held from January 1316, 2025, in San Francisco, brought together a vibrant ecosystem of global pharma stakeholders, innovative startups, emerging biotech companies, and investors. Key Examples : Johnson & Johnson announced the acquisition of Intra-Cellular Therapies, Inc.

Biotechnology 52

Biotechnology Mergers and acquisition activities Biotech Biopharma 52